MKI67 and breast carcinoma: Similarly to Oh et al.’s data set derived from 189 breast carcinoma patients, we show in our present study that, in specimens obtained from 269 breast cancer patients, low NDRG2 expression was associated with advanced TNM stage, high Ki67 and HER2 expression and poor histological differentiation.